Cantrell Drug Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
Cantrell Drug Company is recalling Ephedrine Sulfate in 0.9% Sodium Chloride single-dose syringes because of a lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of sterility assurance in a parenteral drug, which poses a significant risk of serious injury or infection.
Plain-English summary
Cantrell Drug Company is recalling Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL single-dose syringes (NDC 52533-019-15). The recall involves 25,529 syringes distributed nationwide within the US. The specific reason for the recall is a lack of sterility assurance.
The affected lots include 9910 and 9928 with a best-use-by date of 7/28/2017; 9962 and 9993 with a best-use-by date of 8/4/2017; and 10333, 10481, and 10538 with a best-use-by date of 9/23/2017. The product is prescription-only.
Healthcare providers and patients should stop using the affected syringes and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 25 mg/5 mL (5 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222, NDC 52533-019-15
- Manufacturer
- Cantrell Drug Company
- Category
- Drug — Injectable
- Hazard
- Affected units
- 25,529
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #: 9910
- 9928
- BUD: 7/28/2017
- 9962
- 9993
- BUD: 8/4/2017
- 10333
- 10481
- 10538
- BUD: 9/23/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by Cantrell Drug Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · Cantrell Drug Company
See all →- SevereCantrell Drug Company Recalls Rocuronium Bromide Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Succinylcholine Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Norepinephrine Bags Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Recalls Neostigmine Methylsulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereCantrell Drug Company Recalls Phenylephrine HCl Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-12-21
- SevereCantrell Drug Recalls Heparin Sodium Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-12-21
- SevereSCA Pharmaceuticals Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2021-01-13
- SevereCantrell Drug Recalls Hydromorphone Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-12-21
- SeverePharmakon Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- ModerateSCA Pharmaceuticals Recalls Ephedrine Sulfate Syringes Due to Missing Labeling
FDA (Drugs) · 2018-01-17